{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:39:14Z","timestamp":1778661554990,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,8,14]],"date-time":"2008-08-14T00:00:00Z","timestamp":1218672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s12031-008-9137-8","type":"journal-article","created":{"date-parts":[[2008,8,13]],"date-time":"2008-08-13T12:49:13Z","timestamp":1218631753000},"page":"128-142","source":"Crossref","is-referenced-by-count":42,"title":["Implication of NMDA Receptors in the Antidyskinetic Activity of Cabergoline, CI-1041, and Ro 61-8048 in MPTP Monkeys with Levodopa-induced Dyskinesias"],"prefix":"10.1007","volume":"38","author":[{"given":"Bazoumana","family":"Ouattara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samah","family":"Belkhir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Morissette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Dridi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pershia","family":"Samadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Gr\u00e9goire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard T.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th\u00e9r\u00e8se","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,14]]},"reference":[{"key":"9137_CR1","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/mds.20976","volume":"21","author":"W. Bara-Jimenez","year":"2006","unstructured":"Bara-Jimenez, W., Dimitrova, T. D., Sherzai, A., Aksu, M., & Chase, T. N. (2006). Glutamate release inhibition ineffective in levodopa-induced motor complications. Movement Disorders, 21, 1380\u20131383. doi: 10.1002\/mds.20976 .","journal-title":"Movement Disorders"},{"key":"9137_CR2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(02)00776-6","volume":"35","author":"A. Barria","year":"2002","unstructured":"Barria, A., & Malinow, R. (2002). Subunit-specific NMDA receptor trafficking to synapses. Neuron, 35, 345\u2013353. doi: 10.1016\/S0896-6273(02)00776-6 .","journal-title":"Neuron"},{"key":"9137_CR3","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/mds.10589","volume":"18","author":"N. Belanger","year":"2003","unstructured":"Belanger, N., Gregoire, L., Hadj Tahar, A., & Bedard, P. J. (2003). Chronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in parkinsonian monkeys. Movement Disorders, 18, 1436\u20131441. doi: 10.1002\/mds.10589 .","journal-title":"Movement Disorders"},{"key":"9137_CR4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.parkreldis.2004.02.011","volume":"10","author":"P. J. Blanchet","year":"2004","unstructured":"Blanchet, P. J., Calon, F., Morissette, M., et al. (2004). Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms. Parkinsonism & Related Disorders, 10, 297\u2013304. doi: 10.1016\/j.parkreldis.2004.02.011 .","journal-title":"Parkinsonism & Related Disorders"},{"key":"9137_CR5","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.1098805","volume":"304","author":"T. Bliss","year":"2004","unstructured":"Bliss, T., & Schoepfer, R. (2004). Neuroscience. Controlling the ups and downs of synaptic strength. Science, 304, 973\u2013974. doi: 10.1126\/science.1098805 .","journal-title":"Science"},{"key":"9137_CR6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00702-004-0251-7","volume":"112","author":"J. M. Brotchie","year":"2005","unstructured":"Brotchie, J. M., Lee, J., & Venderova, K. (2005). Levodopa-induced dyskinesia in Parkinson\u2019s disease. Journal of Neural Transmission, 112, 359\u2013391. doi: 10.1007\/s00702-004-0251-7 .","journal-title":"Journal of Neural Transmission"},{"key":"9137_CR7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S1474-4422(06)70600-7","volume":"5","author":"P. Calabresi","year":"2006","unstructured":"Calabresi, P., Picconi, B., Parnetti, L., & Di Filippo, M. (2006). A convergent model for cognitive dysfunctions in Parkinson\u2019s disease: the critical dopamine-acetylcholine synaptic balance. The Lancet Neurology, 5, 974\u2013983. doi: 10.1016\/S1474-4422(06)70600-7 .","journal-title":"The Lancet Neurology"},{"key":"9137_CR8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0278-5846(01)00237-8","volume":"26","author":"F. Calon","year":"2002","unstructured":"Calon, F., Morissette, M., Ghribi, O., et al. (2002). Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 26, 127\u2013138. doi: 10.1016\/S0278-5846(01)00237-8 .","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"9137_CR9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2003.07.003","volume":"14","author":"F. Calon","year":"2003","unstructured":"Calon, F., Rajput, A. H., Hornykiewicz, O., Bedard, P. J., & Di Paolo, T. (2003). Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson\u2019s disease. Neurobiology of Disease, 14, 404\u2013416. doi: 10.1016\/j.nbd.2003.07.003 .","journal-title":"Neurobiology of Disease"},{"key":"9137_CR10","doi-asserted-by":"crossref","first-page":"9576","DOI":"10.1073\/pnas.90.20.9576","volume":"90","author":"C. Cepeda","year":"1993","unstructured":"Cepeda, C., Buchwald, N. A., & Levine, M. S. (1993). Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proceedings of the National Academy of Sciences of the United States of America, 90, 9576\u20139580. doi: 10.1073\/pnas.90.20.9576 .","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9137_CR11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.parkreldis.2004.02.012","volume":"10","author":"T. N. Chase","year":"2004","unstructured":"Chase, T. N. (2004). Striatal plasticity and extrapyramidal motor dysfunction. Parkinsonism & Related Disorders, 10, 305\u2013313. doi: 10.1016\/j.parkreldis.2004.02.012 .","journal-title":"Parkinsonism & Related Disorders"},{"key":"9137_CR12","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1023\/A:1023493821302","volume":"20","author":"L. R. Chen","year":"2003","unstructured":"Chen, L. R., Wesley, J. A., Bhattachar, S., Ruiz, B., Bahash, K., & Babu, S. R. (2003). Dissolution behavior of a poorly water soluble compound in the presence of Tween 80. Pharmaceutical Research, 20, 797\u2013801. doi: 10.1023\/A:1023493821302 .","journal-title":"Pharmaceutical Research"},{"key":"9137_CR13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0306-4522(92)90249-2","volume":"47","author":"J. M. Desce","year":"1992","unstructured":"Desce, J. M., Godeheu, G., Galli, T., et al. (1992). L-glutamate-evoked release of dopamine from synaptosomes of the rat striatum: involvement of AMPA and N-methyl-D-aspartate receptors. Neuroscience, 47, 333\u2013339. doi: 10.1016\/0306-4522(92)90249-2 .","journal-title":"Neuroscience"},{"key":"9137_CR14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF01245232","volume":"91","author":"A. Y. Deutch","year":"1993","unstructured":"Deutch, A. Y. (1993). Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson\u2019s disease. Journal of Neural Transmission, 91, 197\u2013221. doi: 10.1007\/BF01245232 .","journal-title":"Journal of Neural Transmission"},{"key":"9137_CR15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0026-895X(24)23206-5","volume":"57","author":"A. W. Dunah","year":"2000","unstructured":"Dunah, A. W., Wang, Y., Yasuda, R. P., et al. (2000). Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson\u2019s disease. Molecular Pharmacology, 57, 342\u2013352.","journal-title":"Molecular Pharmacology"},{"key":"9137_CR16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1615\/CritRevNeurobiol.v16.i3.10","volume":"16","author":"K. Erreger","year":"2004","unstructured":"Erreger, K., Chen, P. E., Wyllie, D. J., & Traynelis, S. F. (2004). Glutamate receptor gating. Critical Reviews in Neurobiology, 16, 187\u2013224. doi: 10.1615\/CritRevNeurobiol.v16.i3.10 .","journal-title":"Critical Reviews in Neurobiology"},{"key":"9137_CR17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1113\/jphysiol.2004.080028","volume":"563","author":"K. Erreger","year":"2005","unstructured":"Erreger, K., Dravid, S. M., Banke, T. G., Wyllie, D. J., & Traynelis, S. F. (2005). Subunit-specific gating controls rat NR1\/NR2A and NR1\/NR2B NMDA channel kinetics and synaptic signalling profiles. The Journal of Physiology, 563, 345\u2013358. doi: 10.1113\/jphysiol.2004.080028 .","journal-title":"The Journal of Physiology"},{"key":"9137_CR18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1124\/mol.107.037333","volume":"72","author":"K. Erreger","year":"2007","unstructured":"Erreger, K., Geballe, M. T., Kristensen, A., et al. (2007). Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors. Molecular Pharmacology, 72, 907\u2013920. doi: 10.1124\/mol.107.037333 .","journal-title":"Molecular Pharmacology"},{"key":"9137_CR19","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1152\/jn.00860.2006","volume":"97","author":"R. C. Gerkin","year":"2007","unstructured":"Gerkin, R. C., Lau, P. M., Nauen, D. W., Wang, Y. T., & Bi, G. Q. (2007). Modular competition driven by NMDA receptor subtypes in spike-timing-dependent plasticity. Journal of Neurophysiology, 97, 2851\u20132862. doi: 10.1152\/jn.00860.2006 .","journal-title":"Journal of Neurophysiology"},{"key":"9137_CR20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1034\/j.1600-0773.2003.930108.x","volume":"93","author":"Y. Gilgun-Sherki","year":"2003","unstructured":"Gilgun-Sherki, Y., Melamed, E., Ziv, I., & Offen, D. (2003). Riluzole, an inhibitor of glutamatergic transmission, suppresses levodopa-induced rotations in 6-hydroxydopamine-lesioned rats. Pharmacology & Toxicology, 93, 54\u201356. doi: 10.1034\/j.1600-0773.2003.930108.x .","journal-title":"Pharmacology & Toxicology"},{"key":"9137_CR21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbr.2007.08.007","volume":"186","author":"L. Gregoire","year":"2008","unstructured":"Gregoire, L., Rassoulpour, A., Guidetti, P., et al. (2008). Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys. Behavioural Brain Research, 186, 161\u2013167. doi: 10.1016\/j.bbr.2007.08.007 .","journal-title":"Behavioural Brain Research"},{"key":"9137_CR22","doi-asserted-by":"crossref","first-page":"10165","DOI":"10.1523\/JNEUROSCI.1772-07.2007","volume":"27","author":"L. Groc","year":"2007","unstructured":"Groc, L., Choquet, D., Stephenson, F. A., et al. (2007). NMDA receptor surface trafficking and synaptic subunit composition are developmentally regulated by the extracellular matrix protein Reelin. The Journal of Neuroscience, 27, 10165\u201310175. doi: 10.1523\/JNEUROSCI.1772-07.2007 .","journal-title":"The Journal of Neuroscience"},{"key":"9137_CR23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.nbd.2003.10.007","volume":"15","author":"A. Hadj Tahar","year":"2004","unstructured":"Hadj Tahar, A., Gregoire, L., Darre, A., et al. (2004). Effect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys. Neurobiology of Disease, 15, 171\u2013176. doi: 10.1016\/j.nbd.2003.10.007 .","journal-title":"Neurobiology of Disease"},{"key":"9137_CR24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neuropharm.2004.11.008","volume":"48","author":"P. J. Hallett","year":"2005","unstructured":"Hallett, P. J., Dunah, A. W., Ravenscroft, P., et al. (2005). Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson\u2019s disease. Neuropharmacology, 48, 503\u2013516. doi: 10.1016\/j.neuropharm.2004.11.008 .","journal-title":"Neuropharmacology"},{"key":"9137_CR25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0306-4522(00)00235-9","volume":"99","author":"L. He","year":"2000","unstructured":"He, L., Di Monte, D. A., Langston, J. W., & Quik, M. (2000). Autoradiographic analysis of N-methyl-D-aspartate receptor binding in monkey brain: effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and levodopa treatment. Neuroscience, 99, 697\u2013704. doi: 10.1016\/S0306-4522(00)00235-9 .","journal-title":"Neuroscience"},{"key":"9137_CR26","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","volume":"21","author":"C. Hilmas","year":"2001","unstructured":"Hilmas, C., Pereira, E. F., Alkondon, M., et al. (2001). The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. The Journal of Neuroscience, 21, 7463\u20137473.","journal-title":"The Journal of Neuroscience"},{"key":"9137_CR27","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1111\/j.1460-9568.2005.04169.x","volume":"21","author":"M. J. Hurley","year":"2005","unstructured":"Hurley, M. J., Jackson, M. J., Smith, L. A., Rose, S., & Jenner, P. (2005). Immunoautoradiographic analysis of NMDA receptor subunits and associated postsynaptic density proteins in the brain of dyskinetic MPTP-treated common marmosets. The European Journal of Neuroscience, 21, 3240\u20133250. doi: 10.1111\/j.1460-9568.2005.04169.x .","journal-title":"The European Journal of Neuroscience"},{"key":"9137_CR28","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1523\/JNEUROSCI.1890-04.2004","volume":"24","author":"G. Lavezzari","year":"2004","unstructured":"Lavezzari, G., McCallum, J., Dewey, C. M., & Roche, K. W. (2004). Subunit-specific regulation of NMDA receptor endocytosis. The Journal of Neuroscience, 24, 6383\u20136391. doi: 10.1523\/JNEUROSCI.1890-04.2004 .","journal-title":"The Journal of Neuroscience"},{"key":"9137_CR29","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0022-3565(25)21065-5","volume":"251","author":"G. Maura","year":"1989","unstructured":"Maura, G., Carbone, R., & Raiteri, M. (1989). Aspartate-releasing nerve terminals in rat striatum possess D-2 dopamine receptors mediating inhibition of release. The Journal of Pharmacology and Experimental Therapeutics, 251, 1142\u20131146.","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"9137_CR30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/mds.20654","volume":"21","author":"M. Morissette","year":"2006","unstructured":"Morissette, M., Dridi, M., Calon, F., et al. (2006). Prevention of levodopa-induced dyskinesias by a selective NR1A\/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin. Movement Disorders, 21, 9\u201317. doi: 10.1002\/mds.20654 .","journal-title":"Movement Disorders"},{"key":"9137_CR31","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neuropharm.2004.10.019","volume":"48","author":"F. Moroni","year":"2005","unstructured":"Moroni, F., Cozzi, A., Carpendo, R., et al. (2005). Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus. Neuropharmacology, 48, 788\u2013795. doi: 10.1016\/j.neuropharm.2004.10.019 .","journal-title":"Neuropharmacology"},{"key":"9137_CR32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1567202054368326","volume":"2","author":"H. Nemeth","year":"2005","unstructured":"Nemeth, H., Toldi, J., & Vecsei, L. (2005). Role of kynurenines in the central and peripheral nervous systems. Current Neurovascular Research, 2, 249\u2013260. doi: 10.2174\/1567202054368326 .","journal-title":"Current Neurovascular Research"},{"key":"9137_CR33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","volume":"6","author":"B. Picconi","year":"2003","unstructured":"Picconi, B., Centonze, D., Hakansson, K., et al. (2003). Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nature Neuroscience, 6, 501\u2013506.","journal-title":"Nature Neuroscience"},{"key":"9137_CR34","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.neuro.2005.02.002","volume":"26","author":"B. Picconi","year":"2005","unstructured":"Picconi, B., Pisani, A., Barone, I., et al. (2005). Pathological synaptic plasticity in the striatum: implications for Parkinson\u2019s disease. Neurotoxicology, 26, 779\u2013783. doi: 10.1016\/j.neuro.2005.02.002 .","journal-title":"Neurotoxicology"},{"key":"9137_CR35","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.neurobiolaging.2007.02.005","volume":"29","author":"P. Samadi","year":"2008","unstructured":"Samadi, P., Gregoire, L., Morissette, M., et al. (2008). mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys. Neurobiology of Aging, 29, 1040\u20131051. doi: 10.1016\/j.neurobiolaging.2007.02.005 .","journal-title":"Neurobiology of Aging"},{"key":"9137_CR36","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/mds.20596","volume":"20","author":"P. Samadi","year":"2005","unstructured":"Samadi, P., Gregoire, L., Rassoulpour, A., et al. (2005). Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys. Movement Disorders, 20, 792\u2013802. doi: 10.1002\/mds.20596 .","journal-title":"Movement Disorders"},{"key":"9137_CR37","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/j.1471-4159.1990.tb04893.x","volume":"54","author":"D. Samuel","year":"1990","unstructured":"Samuel, D., Errami, M., & Nieoullon, A. (1990). Localization of N-methyl-D-aspartate receptors in the rat striatum: effects of specific lesions on the [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid binding. Journal of Neurochemistry, 54, 1926\u20131933. doi: 10.1111\/j.1471-4159.1990.tb04893.x .","journal-title":"Journal of Neurochemistry"},{"key":"9137_CR38","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/jama.1969.03160070046011","volume":"208","author":"R. S. Schwab","year":"1969","unstructured":"Schwab, R. S., England, A. C., Jr., Poskanzer, D. C., & Young, R. R. (1969). Amantadine in the treatment of Parkinson\u2019s disease. Journal of the American Medical Association, 208, 1168\u20131170. doi: 10.1001\/jama.208.7.1168 .","journal-title":"Journal of the American Medical Association"},{"key":"9137_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.034439","volume":"303","author":"R. Schwarcz","year":"2002","unstructured":"Schwarcz, R., & Pellicciari, R. (2002). Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. The Journal of Pharmacology and Experimental Therapeutics, 303, 1\u201310. doi: 10.1124\/jpet.102.034439 .","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"9137_CR40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-6147(00)01451-6","volume":"21","author":"T. W. Stone","year":"2000","unstructured":"Stone, T. W. (2000). Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection. Trends in Pharmacological Sciences, 21, 149\u2013154. doi: 10.1016\/S0165-6147(00)01451-6 .","journal-title":"Trends in Pharmacological Sciences"},{"key":"9137_CR41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/cne.902220208","volume":"222","author":"J. Szabo","year":"1984","unstructured":"Szabo, J., & Cowan, W. M. (1984). A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis). The Journal of Comparative Neurology, 222, 265\u2013300. doi: 10.1002\/cne.902220208 .","journal-title":"The Journal of Comparative Neurology"},{"key":"9137_CR42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/pgmj.2006.054759","volume":"83","author":"B. Thanvi","year":"2007","unstructured":"Thanvi, B., Lo, N., & Robinson, T. (2007). Levodopa-induced dyskinesia in Parkinson\u2019s disease: clinical features, pathogenesis, prevention and treatment. Postgraduate Medical Journal, 83, 384\u2013388. doi: 10.1136\/pgmj.2006.054759 .","journal-title":"Postgraduate Medical Journal"},{"key":"9137_CR43","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0896-6273(02)00658-X","volume":"34","author":"K. R. Tovar","year":"2002","unstructured":"Tovar, K. R., & Westbrook, G. L. (2002). Mobile NMDA receptors at hippocampal synapses. Neuron, 34, 255\u2013264. doi: 10.1016\/S0896-6273(02)00658-X .","journal-title":"Neuron"},{"key":"9137_CR44","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1523\/JNEUROSCI.14-11-06317.1994","volume":"14","author":"J. Ulas","year":"1994","unstructured":"Ulas, J., Weihmuller, F. B., Brunner, L. C., et al. (1994). Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson\u2019s disease, Alzheimer\u2019s disease, and mixed Parkinson\u2019s disease\/Alzheimer\u2019s disease patients: an autoradiographic study. The Journal of Neuroscience, 14, 6317\u20136324.","journal-title":"The Journal of Neuroscience"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-008-9137-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-008-9137-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-008-9137-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T12:51:18Z","timestamp":1738327878000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-008-9137-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,14]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["9137"],"URL":"https:\/\/doi.org\/10.1007\/s12031-008-9137-8","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,14]]}}}